RAS and Coagulopathy in COVID19
Investigating the Relationship Between the Renin Angiotensin System and the Coagulopathy Associated With COVID-19
Sponsor: Imperial College London
A EARLY_PHASE1 clinical study on COVID, this trial is completed. The trial is conducted by Imperial College London and has accumulated 12 data snapshots since 2020. Infectious disease trials contribute critical data for public health response and treatment development.
Status Flow
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
Completed EARLY_PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Completed EARLY_PHASE1
-
Jun 2024 — Jul 2024 [monthly]
Completed EARLY_PHASE1
-
Jun 2021 — Jun 2024 [monthly]
Completed EARLY_PHASE1
Status: Recruiting → Completed
-
May 2021 — Jun 2021 [monthly]
Recruiting EARLY_PHASE1
▶ Show 7 earlier versions
-
Apr 2021 — May 2021 [monthly]
Recruiting EARLY_PHASE1
-
Mar 2021 — Apr 2021 [monthly]
Recruiting EARLY_PHASE1
-
Jan 2021 — Mar 2021 [monthly]
Recruiting EARLY_PHASE1
-
Nov 2020 — Jan 2021 [monthly]
Recruiting EARLY_PHASE1
Status: Not Yet Recruiting → Recruiting
-
Sep 2020 — Nov 2020 [monthly]
Not Yet Recruiting EARLY_PHASE1
-
Aug 2020 — Sep 2020 [monthly]
Not Yet Recruiting EARLY_PHASE1
-
Jul 2020 — Aug 2020 [monthly]
Not Yet Recruiting EARLY_PHASE1
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Imperial College London
For direct contact, visit the study record on ClinicalTrials.gov .